Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Biomedical Refrigerators and Freezers Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
Graphical Research
Graphical Research

Major biomedical refrigerators and freezers market players include Thermo Fisher Scientific, Panasonic Healthcare, Liebherr International, Helmer Scientific, Haier Biomedical, Follett, Eppendorf, Binder, B Medical, Azbil, Arctiko, Aegis Scientific, Migali Scientific, and Powers Scientific.

Pune, India, Sept. 06, 2022 (GLOBE NEWSWIRE) --

The global biomedical refrigerators and freezers market size is projected to expand at substantial CAGR during the forecast period, due to increased focus on drug discovery and medical R&D during the COVID-19 pandemic. Listed below are the 6 factors driving global market trends over 2022-2028:


  1. Lab freezers see healthy demand in Asia Pacific

With steady expansion of integrated labs in the region, Asia Pacific biomedical refrigerators and lab freezers market revenue is expected to surpass the valuation of $80 million by 2028. To capture the large population pool of customers in the region, leading companies across the globe have been aiming to expand their businesses in Asia Pacific.

For instance, in November 2021, Labcorp opened an integrated bioanalytical lab in Singapore. This new lab expansion was intended to deliver a substantial array of bioanalytical services to meet the burgeoning demand from biotech and pharma companies.

With strong emphasis on supporting the development of large and small molecule studies, the demand for biomedical lab freezers is likely to see significant upheaval through 2028.

Access sample pages of the report, “Asia Pacific Biomedical Refrigerators and Freezers Market Forecasts 2028” in detail along with the table of contents (ToC) @

https://www.graphicalresearch.com/request/1010/sample

  1. Research labs in APAC address diverse patient needs amidst global health crises

The increased threat of infectious and chronic illness emergence across the globe have ushered technological advancements and drug discovery efforts in Asia Pacific. For the long-term preservation of biological reagents and materials, a variety of laboratory freezers and refrigerators are used in drug development.

With growing investment in pharmaceutical R&D, Asia Pacific is emerging as a valuable income source for the industry. Pfizer, for example, committed about $18.9 million in a 61,000-square-foot research and technology facility at the IIT Madras Research Park in May 2022.

This new drug development center was constructed to help the regional and global pharmaceutical markets with vital drug development. The growing geriatric population of the region that is susceptible to chronic and infectious diseases has been boosting the rate of drug discoveries, plasma collections, and blood transfusions.